Speech therapy to improve lip-reading for people who use hearing aids
Official title: Efficacité de la rééducation Orthophonique de la Lecture Labiale Des Patients appareillés Auditifs : étude SCED
Run by Institut Pasteur · NCT07028658 · Data updated 2026-11-12
This will see if speech therapy for lip-reading improves visual speech recognition in adults with moderate-to-severe hearing loss who wear hearing aids.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 8 (estimated) |
| Sponsor | Institut Pasteur Industry-sponsored |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | October 16, 2025 |
| Main results expected | September 2026 |
| Study ends | September 2026 |
| Registry record updated | April 3, 2026 |
| Trial ID | NCT07028658 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with post-lingual moderate-to-severe unilateral or bilateral hearing loss who have used hearing aids at least 8 hours per day for over six months, score >80% intelligibility in quiet, and report difficulty hearing in noise.
✕Probably not a fit
People who have already had speech therapy for hearing loss, those with significant uncorrected visual impairment, or those with neurodegenerative disease or recent brain injury are unlikely to benefit or are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational single-case experimental design offers targeted speechreading training twice weekly to adults with post-lingual moderate-to-severe hearing loss who have been using hearing aids for at least six months. Participants continue wearing their hearing aids and complete baseline and repeated measures of viseme recognition and speech intelligibility, including testing in noisy environments. The study excludes people with prior speech therapy for their hearing loss, neurodegenerative disease, recent brain injury, or uncorrected visual impairment that affects lip reading. Individual trajectories will be compared over time to determine whether lip-reading rehabilitation produces measurable improvements.
Why it matters
Potential benefit: If successful, patients may gain improved ability to understand speech visually and in noisy settings, reducing everyday communication difficulties.
How similar studies have gone: Previous research has shown some benefit from speechreading training for improving visual speech perception, but results are mixed and larger controlled studies are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient aged 18 or older * Affiliated with a social security system * Moderate to severe bilateral post-lingual hearing loss, fitted with hearing aids for more than 6 months * Wearing hearing aids for a minimum of 8 hours/day on average over the past month * Intelligibility in quiet \> 80% correct responses at 60 dB (Lafon cochlear list) * Difficulty in noisy environments rated \> 6 on a 0-10 EVA scale * French language comprehension level of at least B1 CEFR (Common European Framework of Reference for Languages) * Willing to participate in speech therapy rehabilitation at a rate of 2 sessions per week Exclusion Criteria: * Patient who has already undergone speech therapy rehabilitation as part of their hearing loss treatment * Diagnosis of neurodegenerative disease or history of brain injury (traumatic brain injury, stroke, tumor, meningitis, etc.) * Uncorrected vision or visual impairment affecting lip reading (e.g. AMD, glaucoma, unoperated cataract, etc.) * Presence of severe tinnitus (score \> 56) on the Tinnitus Handicap Inventory (THI) questionnaire * Significant cognitive impairment (CODEX C or D) or Montreal Cognitive Assessment (MOCA) score \< 23
Where it's running
-
Cabinet d'orthophonie
Paris, France Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Universal newborn hearing screening in Kenya using smartphone tests
This study tests whether smartphone hearing screening can help identify ear infections and hearing loss in infants, including those exposed to HIV, over 6 months.
-
Evaluating a Tinnitus Implant for Chronic Tinnitus Relief
This study is testing a new implant for adults with chronic tinnitus to see if it can help reduce their symptoms and improve their quality of life.
-
MOPEVAC-Las vaccine in healthy adults to test safety and immune response for Lassa fever
A small study in healthy adults checks if MOPEVAC-Las is safe and can trigger an immune response, trying different dose levels.
-
Testing for viruses after a monkey bite
We will test adults who were recently bitten by a monkey or who have a history of monkey bites to see if they carry simian viruses such as STLV-1 or SFV using blood and saliva samples.
-
How breast milk affects virus infectivity and transmission
This project will test whether components of donated breast milk change how viruses such as HTLV-1, Zika, dengue, yellow fever, and tick-borne encephalitis infect cells and could affect transmission.
-
Exploring immune responses to yellow fever vaccination
This study is testing whether yellow fever and typhoid vaccines can boost the immune system's ability to fight off other infections, and it involves collecting blood samples from participants after they get vaccinated.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.